Details of the Drug
General Information of Drug (ID: DMGLDFI)
Drug Name |
PHENYLMETHANESULFONAMIDE
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Phenylmethanesulfonamide; 4563-33-1; Benzenemethanesulfonamide; Benzylsulfonamide; alpha-Toluenesulfonamide; Methanesulfonamide, 1-phenyl-; .alpha.-Toluenesulfonamide; 1-phenylmethanesulfonamide; Toluene-.omega.-sulfonamide; CHEMBL369953; ABOYDMHGKWRPFD-UHFFFAOYSA-N; Toluene-alpha-sulphonamide; benzyl-sulfonamide; a-toluenesulfonamide; NSC28899; EINECS 224-935-0; NSC 28899; phenylmethansulfonamide; alphatoluenesulfonamide; PubChem10753; 1-phenylmethylsulfonamid; phenylmethane sulfonamide; phenyl-methanesulfonamide; alpha-toluene
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 171.22 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.1 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||||||||